Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002214.SZ
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -3.44 5.15 5.33
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 178.57 -1.11 0.40
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -1.77 3.16 3.22
Cash -0.63 0.45 0.45
Capex -7.86 -0.05 -0.04
Free Cash Flow -59.92 -0.13 -0.08
Revenue -58.62 0.05 0.12
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 8.48 0.31 0.29
Operating Margin -71.10 -2.77 -1.62
ROA 39.02 -0.03 -0.05
ROE 36.96 -0.04 -0.07
ROIC 38.69 -0.04 -0.06
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002214.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002214.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002214.SZ is permitted for members.